Search

Thuy V Tran

Examiner (ID: 6857, Phone: (571)272-1828 , Office: P/2844 )

Most Active Art Unit
2821
Art Unit(s)
2821, 2844, 2856, 2814
Total Applications
2202
Issued Applications
1909
Pending Applications
47
Abandoned Applications
246

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 16282569 [patent_doc_number] => 20200276171 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-09-03 [patent_title] => COMBINATION THERAPY USING AZABICYCLO COMPOUND FOR CANCER [patent_app_type] => utility [patent_app_number] => 16/877959 [patent_app_country] => US [patent_app_date] => 2020-05-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17939 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -16 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16877959 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/877959
Combination therapy using azabicyclo compound for cancer May 18, 2020 Issued
Array ( [id] => 17434709 [patent_doc_number] => 11260015 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2022-03-01 [patent_title] => Compositions and methods for improving skin appearance [patent_app_type] => utility [patent_app_number] => 16/877315 [patent_app_country] => US [patent_app_date] => 2020-05-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 5 [patent_no_of_words] => 9802 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 197 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16877315 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/877315
Compositions and methods for improving skin appearance May 17, 2020 Issued
Array ( [id] => 16389559 [patent_doc_number] => 20200330500 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-10-22 [patent_title] => Mecobalamin for Relieving Emergency Drug Poisoning [patent_app_type] => utility [patent_app_number] => 15/930954 [patent_app_country] => US [patent_app_date] => 2020-05-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 866 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -6 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15930954 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/930954
Mecobalamin for Relieving Emergency Drug Poisoning May 12, 2020 Abandoned
Array ( [id] => 18369014 [patent_doc_number] => 11649168 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2023-05-16 [patent_title] => Purification method of high-purity n-tetrasilane [patent_app_type] => utility [patent_app_number] => 16/870539 [patent_app_country] => US [patent_app_date] => 2020-05-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 1448 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 85 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16870539 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/870539
Purification method of high-purity n-tetrasilane May 7, 2020 Issued
Array ( [id] => 16824360 [patent_doc_number] => 20210139653 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-05-13 [patent_title] => PROCESS FOR THE PRODUCTION OF BIOPRODUCTS FROM LIGNOCELLULOSIC MATERIAL [patent_app_type] => utility [patent_app_number] => 16/866266 [patent_app_country] => US [patent_app_date] => 2020-05-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11005 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -12 [patent_words_short_claim] => 450 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16866266 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/866266
Process for the production of bioproducts from lignocellulosic material May 3, 2020 Issued
Array ( [id] => 16253442 [patent_doc_number] => 20200262816 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-08-20 [patent_title] => ISOINDOLINE OR ISOQUINOLINE COMPOUNDS, A PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM [patent_app_type] => utility [patent_app_number] => 16/865799 [patent_app_country] => US [patent_app_date] => 2020-05-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 41832 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -12 [patent_words_short_claim] => 866 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16865799 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/865799
Isoindoline or isoquinoline compounds, a process for their preparation and pharmaceutical compositions containing them May 3, 2020 Issued
Array ( [id] => 16326888 [patent_doc_number] => 20200297853 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-09-24 [patent_title] => CARBOHYDRATE CONJUGATES AS DELIVERY AGENTS FOR OLIGONUCLEOTIDES [patent_app_type] => utility [patent_app_number] => 16/861494 [patent_app_country] => US [patent_app_date] => 2020-04-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 56684 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 330 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16861494 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/861494
Carbohydrate conjugates as delivery agents for oligonucleotides Apr 28, 2020 Issued
Array ( [id] => 16236871 [patent_doc_number] => 20200254105 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-08-13 [patent_title] => DRUG COMPOSITION FOR PARENTERAL ADMINISTRATION [patent_app_type] => utility [patent_app_number] => 16/858810 [patent_app_country] => US [patent_app_date] => 2020-04-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7048 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -10 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16858810 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/858810
Drug composition for parenteral administration Apr 26, 2020 Issued
Array ( [id] => 16229343 [patent_doc_number] => 10736872 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2020-08-11 [patent_title] => Pharmaceutical mixture to treat statin induced vascular calcification [patent_app_type] => utility [patent_app_number] => 16/853519 [patent_app_country] => US [patent_app_date] => 2020-04-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 9 [patent_no_of_words] => 5818 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 33 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16853519 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/853519
Pharmaceutical mixture to treat statin induced vascular calcification Apr 19, 2020 Issued
Array ( [id] => 17149446 [patent_doc_number] => 11142508 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2021-10-12 [patent_title] => Bisphenol derivatives and their use as androgen receptor activity modulators [patent_app_type] => utility [patent_app_number] => 16/848061 [patent_app_country] => US [patent_app_date] => 2020-04-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 28282 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 175 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16848061 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/848061
Bisphenol derivatives and their use as androgen receptor activity modulators Apr 13, 2020 Issued
Array ( [id] => 16523660 [patent_doc_number] => 20200397740 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-12-24 [patent_title] => 2-ACETYLNAPHTHO[2,3-B]FURAN -4,9-DIONE FOR USE ON TREATING CANCER [patent_app_type] => utility [patent_app_number] => 16/841807 [patent_app_country] => US [patent_app_date] => 2020-04-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 40126 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -12 [patent_words_short_claim] => 77 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16841807 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/841807
2-ACETYLNAPHTHO[2,3-B]FURAN -4,9-DIONE FOR USE ON TREATING CANCER Apr 6, 2020 Abandoned
Array ( [id] => 16389531 [patent_doc_number] => 20200330472 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-10-22 [patent_title] => METHOD OF TREATING CANCER [patent_app_type] => utility [patent_app_number] => 16/841097 [patent_app_country] => US [patent_app_date] => 2020-04-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 23439 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16841097 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/841097
METHOD OF TREATING CANCER Apr 5, 2020 Abandoned
Array ( [id] => 16204803 [patent_doc_number] => 20200237793 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-07-30 [patent_title] => IMMUNOMODULATORY OLIGOSACCHARIDES [patent_app_type] => utility [patent_app_number] => 16/840026 [patent_app_country] => US [patent_app_date] => 2020-04-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15568 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -10 [patent_words_short_claim] => 53 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16840026 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/840026
IMMUNOMODULATORY OLIGOSACCHARIDES Apr 2, 2020 Abandoned
Array ( [id] => 16189312 [patent_doc_number] => 20200230161 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-07-23 [patent_title] => IMMUNOMODULATORY OLIGOSACCHARIDES [patent_app_type] => utility [patent_app_number] => 16/840059 [patent_app_country] => US [patent_app_date] => 2020-04-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15525 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -10 [patent_words_short_claim] => 52 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16840059 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/840059
IMMUNOMODULATORY OLIGOSACCHARIDES Apr 2, 2020 Abandoned
Array ( [id] => 16769674 [patent_doc_number] => 10980756 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2021-04-20 [patent_title] => Methods of treatment [patent_app_type] => utility [patent_app_number] => 16/835307 [patent_app_country] => US [patent_app_date] => 2020-03-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 38956 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 142 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16835307 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/835307
Methods of treatment Mar 30, 2020 Issued
Array ( [id] => 16341731 [patent_doc_number] => 20200306381 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-10-01 [patent_title] => COMPOSITIONS AND METHODS FOR ALTERING MACROPHAGE PHENOTYPE [patent_app_type] => utility [patent_app_number] => 16/832620 [patent_app_country] => US [patent_app_date] => 2020-03-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11320 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 41 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16832620 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/832620
Compositions and methods for altering macrophage phenotype Mar 26, 2020 Issued
Array ( [id] => 17156092 [patent_doc_number] => 20210317143 [patent_country] => US [patent_kind] => A9 [patent_issue_date] => 2021-10-14 [patent_title] => BORONIC ESTER PRODRUGS AND USES THEREOF [patent_app_type] => utility [patent_app_number] => 16/825269 [patent_app_country] => US [patent_app_date] => 2020-03-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 47884 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16825269 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/825269
BORONIC ESTER PRODRUGS AND USES THEREOF Mar 19, 2020 Pending
Array ( [id] => 17156092 [patent_doc_number] => 20210317143 [patent_country] => US [patent_kind] => A9 [patent_issue_date] => 2021-10-14 [patent_title] => BORONIC ESTER PRODRUGS AND USES THEREOF [patent_app_type] => utility [patent_app_number] => 16/825269 [patent_app_country] => US [patent_app_date] => 2020-03-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 47884 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16825269 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/825269
BORONIC ESTER PRODRUGS AND USES THEREOF Mar 19, 2020 Pending
Array ( [id] => 16153695 [patent_doc_number] => 20200215080 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-07-09 [patent_title] => 17A-MONOESTERS AND 17A,21-DIESTERS OF CORTEXOLONE FOR USE IN THE TREATMENT OF TUMORS [patent_app_type] => utility [patent_app_number] => 16/820407 [patent_app_country] => US [patent_app_date] => 2020-03-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18354 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -14 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16820407 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/820407
17a-monoesters and 17a,21-diesters of cortexolone for use in the treatment of tumors Mar 15, 2020 Issued
Array ( [id] => 16924327 [patent_doc_number] => 11045786 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2021-06-29 [patent_title] => Superabsorbent materials and methods of making the same [patent_app_type] => utility [patent_app_number] => 16/807004 [patent_app_country] => US [patent_app_date] => 2020-03-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 6 [patent_no_of_words] => 10214 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 143 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16807004 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/807004
Superabsorbent materials and methods of making the same Mar 1, 2020 Issued
Menu